Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1981 Aug;12(2):215–221. doi: 10.1111/j.1365-2125.1981.tb01203.x

Penbutolol or hydrochlorothiazide once a day in hypertension. A controlled study with home measurements.

J F De Plaen, E Vander Elst, C Van Ypersele de Strihou
PMCID: PMC1401847  PMID: 7030372

Abstract

1 The hypotensive effect of single daily dosing with 80 mg penbutolol was compared to 100 mg hydrochlorothiazide and placebo in a double-blind cross-over controlled trial with daily home measurements in ten hypertensive patients. 2 Penbutolol, 80 mg once a day, reduced significantly the supine and standing blood pressure. 3 This hypotensive effect was more potent than hydrochlorothiazide 100 mg particularly in the evening. 4 The hypotensive effect remained for 24 h as shown by the evening (14 h after dose) and morning (24 h after dose) blood pressure readings. 5 No relevant subjective or physical side effects were recorded. There was no significant change nor individual noticeable variation in biochemical data during penbutolol treatment. However, during hydrochlorothiazide treatment, the expected electrolyte changes were observed (symptom-free hypokalemia and hyperuricemia). 6 Penbutolol serum concentration showed no cumulation after one month of treatment. 7 Sudden withdrawal of penbutolol after 1 month of therapy resulted in a slow return to baseline blood pressures over a 2-week period without rebound.

Full text

PDF
215

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Douglas-Jones A. P., Cruickshank J. M. Once-daily dosing with Atenolol in patients with mild or moderate hypertension. Br Med J. 1976 Apr 24;1(6016):990–991. doi: 10.1136/bmj.1.6016.990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Frick M. H., Hartikainen M., Pörsti P. Penbutolol, a new non-selective beta-adrenergic blocking compound in the treatment of hypertension. A comparision with propranolol. Ann Clin Res. 1978 Apr;10(2):105–106. [PubMed] [Google Scholar]
  3. Hajdú P., Damm D. Physico-chemical and anlytical studies of penbutolol. Arzneimittelforschung. 1979;29(4):602–606. [PubMed] [Google Scholar]
  4. Hansson B. G., Hökfelt Long term treatment of moderate hypertension with penbutolol (Hoe 893d). II. Effect on the response of plasma catecholamines and plasma renin activity to insulin-induced hypoglycemia. Eur J Clin Pharmacol. 1976 Feb 6;9(4):245–251. doi: 10.1007/BF00561656. [DOI] [PubMed] [Google Scholar]
  5. Holti G. A double-blind study of the peripheral vasoconstrictor effects of the beta-blocking drug penbutolol in patients with Raynaud's phenomenon. Curr Med Res Opin. 1979;6(4):267–270. doi: 10.1185/03007997909109435. [DOI] [PubMed] [Google Scholar]
  6. Lederballe Pedersen O., Mikkelsen E., Lanng Nielsen J., Christensen N. J. Abrupt withdrawal of beta-blocking agents in patients with arterial hypertension. Effect on blood pressure, heart rate and plasma catecholamines and prolactin. Eur J Clin Pharmacol. 1979 Apr 17;15(3):215–217. doi: 10.1007/BF00563108. [DOI] [PubMed] [Google Scholar]
  7. Miller R. R., Olson H. G., Amsterdam E. A., Mason D. T. Propranolol-withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy. N Engl J Med. 1975 Aug 28;293(9):416–418. doi: 10.1056/NEJM197508282930902. [DOI] [PubMed] [Google Scholar]
  8. Müller F. O., Hundt H. K., Bromley P. A., Torres J., Vanderbeke O. Single and divided doses of penbutolol. Clin Pharmacol Ther. 1979 May;25(5 Pt 1):528–535. doi: 10.1002/cpt1979255part1528. [DOI] [PubMed] [Google Scholar]
  9. O'Brien E. T., MacKinnon J. Propranolol and polythiazide in treatment of hypertension. Br Heart J. 1972 Oct;34(10):1042–1044. doi: 10.1136/hrt.34.10.1042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Pedersen O. L. Comparison of metoprolol as hydrochlorothiazide and antihypertensive agents. Eur J Clin Pharmacol. 1976;10(6):381–385. doi: 10.1007/BF00563073. [DOI] [PubMed] [Google Scholar]
  11. Reybrouck T., Amery A., Fagard R., Jousten P., Lijnen P., Meulepas E. Beta-blockers: once or three times a day? Br Med J. 1978 May 27;1(6124):1386–1388. doi: 10.1136/bmj.1.6124.1386. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Silverberg D. S., Rosenfeld J. B. Comparison of clinic and home blood pressure measurements. Isr J Med Sci. 1980 Jan;16(1):22–24. [PubMed] [Google Scholar]
  13. Vallner J. J., Jun H. W., Needham T. E., Stewart J. T., Brown W., Frazer H., Honigberg I. L. Plasma level studies of penbutolol after oral dose in man. J Clin Pharmacol. 1977 Apr;17(4):231–236. doi: 10.1177/009127007701700407. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES